Mixed connective tissue disease other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Mixed connective tissue disease}} {{CMG}}; {{AE}} {{SHH}} ==Overview== There are no other diagnostic studies associated with [disease name]. OR [Diagnostic stud...") |
|||
| (8 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Spirometry|Pulmonary function test]] may be helpful in the diagnosis of [[interstitial lung disease]] as a [[Complication (medicine)|complication]] of MCTD and [[Right heart catheterization]] is the standard diagnostic approach for definitive diagnosis of [[pulmonary hypertension]] as a [[Complication (medicine)|complication]] of MCTD | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
* | === Pulmonary function test === | ||
*[[Spirometry|Pulmonary function test]] may be helpful in the diagnosis of [[interstitial lung disease]] as a [[Complication (medicine)|complication]] of MCTD. Findings suggestive of [[interstitial lung disease]] include:<ref name="pmid15716315">{{cite journal |vauthors=Bodolay E, Szekanecz Z, Dévényi K, Galuska L, Csípo I, Vègh J, Garai I, Szegedi G |title=Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD) |journal=Rheumatology (Oxford) |volume=44 |issue=5 |pages=656–61 |date=May 2005 |pmid=15716315 |doi=10.1093/rheumatology/keh575 |url=}}</ref><ref name="pmid23125954">{{cite journal |vauthors=Gutsche M, Rosen GD, Swigris JJ |title=Connective Tissue Disease-associated Interstitial Lung Disease: A review |journal=Curr Respir Care Rep |volume=1 |issue= |pages=224–232 |date=September 2012 |pmid=23125954 |pmc=3486427 |doi=10.1007/s13665-012-0028-7 |url=}}</ref> | |||
**[[DLCO]] values is significantly lower in the active pulmonary stage (most [[Sensitivity (tests)|sensitive]] test for predicting the presence of fibrosing [[alveolitis]]) | |||
**[[Restrictive lung disease|Restrictive ventilatory defect]] (reduction of FEV1 and total lung capacity) | |||
=== Right heart catheterization === | |||
*[[Right heart catheterization]] is the standard diagnostic approach for definitive diagnosis of [[pulmonary hypertension]] as a [[Complication (medicine)|complication]] of MCTD.<ref name="pmid27436003">{{cite journal |vauthors=Ciang NC, Pereira N, Isenberg DA |title=Mixed connective tissue disease-enigma variations? |journal=Rheumatology (Oxford) |volume=56 |issue=3 |pages=326–333 |date=March 2017 |pmid=27436003 |doi=10.1093/rheumatology/kew265 |url=}}</ref> | |||
==References== | ==References== | ||
| Line 37: | Line 21: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Rheumatology]] | |||
Latest revision as of 15:14, 8 May 2018
|
Mixed connective tissue disease Microchapters |
|
Differentiating Mixed connective tissue disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mixed connective tissue disease other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Mixed connective tissue disease other diagnostic studies |
|
FDA on Mixed connective tissue disease other diagnostic studies |
|
Mixed connective tissue disease other diagnostic studies in the news |
|
Blogs onMixed connective tissue disease other diagnostic studies |
|
Directions to Hospitals Treating Mixed connective tissue disease |
|
Risk calculators and risk factors for Mixed connective tissue disease other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Pulmonary function test may be helpful in the diagnosis of interstitial lung disease as a complication of MCTD and Right heart catheterization is the standard diagnostic approach for definitive diagnosis of pulmonary hypertension as a complication of MCTD
Other Diagnostic Studies
Pulmonary function test
- Pulmonary function test may be helpful in the diagnosis of interstitial lung disease as a complication of MCTD. Findings suggestive of interstitial lung disease include:[1][2]
- DLCO values is significantly lower in the active pulmonary stage (most sensitive test for predicting the presence of fibrosing alveolitis)
- Restrictive ventilatory defect (reduction of FEV1 and total lung capacity)
Right heart catheterization
- Right heart catheterization is the standard diagnostic approach for definitive diagnosis of pulmonary hypertension as a complication of MCTD.[3]
References
- ↑ Bodolay E, Szekanecz Z, Dévényi K, Galuska L, Csípo I, Vègh J, Garai I, Szegedi G (May 2005). "Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD)". Rheumatology (Oxford). 44 (5): 656–61. doi:10.1093/rheumatology/keh575. PMID 15716315.
- ↑ Gutsche M, Rosen GD, Swigris JJ (September 2012). "Connective Tissue Disease-associated Interstitial Lung Disease: A review". Curr Respir Care Rep. 1: 224–232. doi:10.1007/s13665-012-0028-7. PMC 3486427. PMID 23125954.
- ↑ Ciang NC, Pereira N, Isenberg DA (March 2017). "Mixed connective tissue disease-enigma variations?". Rheumatology (Oxford). 56 (3): 326–333. doi:10.1093/rheumatology/kew265. PMID 27436003.